Early hepatocellular carcinoma treated by radiofrequency Ablation—Mid-and long-term outcomes
Background Radiofrequency ablation (RFA) is a standard treatment for small inoperable
hepatocellular carcinoma (HCC). Studies on mid-and long-term outcome of RFA as first-line
therapy for HCC from India are limited. Methods We evaluated consecutive HCC patients
who underwent RFA as primary treatment modality at our institute between July 2009 and
April 2016. The median follow-up period was 26 months, range 1–84 months. We evaluated
post-RFA tumor response, disease-free survival (DFS), overall survival (OS), and local tumor …
hepatocellular carcinoma (HCC). Studies on mid-and long-term outcome of RFA as first-line
therapy for HCC from India are limited. Methods We evaluated consecutive HCC patients
who underwent RFA as primary treatment modality at our institute between July 2009 and
April 2016. The median follow-up period was 26 months, range 1–84 months. We evaluated
post-RFA tumor response, disease-free survival (DFS), overall survival (OS), and local tumor …
以上显示的是最相近的搜索结果。 查看全部搜索结果